MiMedx Group, Inc (MDXG) Financials

MDXG Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 221.7 million 66.0 million
2023-12-31 239.0 million 96.3 million
2023-09-30 189.0 million 187.7 million
2023-06-30 176.4 million 189.0 million

MDXG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 6.8 million ?
2023-12-31 9.8 million 4.2 million
2023-09-30 12.1 million 4.4 million
2023-06-30 7.4 million 4.1 million

MDXG Net Income

No data available :(

MDXG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 48.5 million - -
2023-12-31 82.0 million - -
2023-09-30 81.2 million - -
2023-06-30 68.7 million - -

MDXG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 150.0 million
2023-12-31 148.1 million
2023-09-30 119.3 million
2023-06-30 115.9 million

MDXG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 - 2.8 million - -
2023-12-31 481000 -5.5 million 54.4 million -
2023-09-30 649000 3.2 million 52.6 million -
2023-06-30 348000 8.5 million 51.9 million -

MDXG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 84.7 million 13.0 million
2023-12-31 86.8 million 13.8 million
2023-09-30 81.7 million 14.8 million
2023-06-30 81.3 million 13.6 million

MDXG

Price: $7.15

52 week price:
3.14
9.27

Earnings Per Share: 0.43 USD

P/E Ratio: -389

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 527584

Ebitda: 10.3 million

Market Capitalization: 1.1 billion

Links: